Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction

被引:16
|
作者
Zhang Xun [1 ]
Watson, David I. [2 ]
Jamieson, Glyn G. [3 ]
机构
[1] Tianjin Chest Hosp, Dept Thorac Surg, Tianjin 300051, Peoples R China
[2] Flinders Univ S Australia, Flinders Med Ctr, Dept Surg, Bedford Pk, SA 5042, Australia
[3] Univ Adelaide, Royal Adelaide Hosp, Dept Surg, Adelaide, SA 5042, Australia
关键词
esophageal carcinoma; adenocarcinoma; metastasis;
D O I
10.1097/00029330-200712020-00022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Esophageal adenocarcinoma is becoming an increasingly important problem. It has been the most rapidly increasing malignancy in western countries in the last decades, and its prognosis is poor. The aim of this study was to evaluate the relationship between tumor invasion depth and lymph node metastasis for adenocarcinoma of the esophagus and esophagogastric junction, and to analyze the impact of lymph node metastases on survival of the patients. Methods The study group comprised 121 patients with adenocarcinoma of the esophagus or esophagogastric junction, who underwent esophagectomy between January 1985 and December 2003 at either the Royal Adelaide Hospital or the Flinders Medical Center, Australia. Overall, there were 101 males and 20 females, with a mean age at surgery of 62 years (range 36-80). All of them were followed up for 6 months to 13 years (mean, 6.5 years). The relationship between tumor invasion depth and lymph node metastasis, as well as between survival and lymph node metastasis in these patients were analyzed by Chi-square or Fisher's exact test. A P < 0.05 was considered statistically significant. Results The tumors were located entirely within the esophagus in 83 patients, and involved the gastro-esophageal junction in 38. The overall resection rate was 96.7% (117/121). When tumor invasion was within mucosa or submucosa of the esophagus (T-1), the lymph node metastasis rate was 22.2% (10/45), the mean number of metastatic lymph nodes was 0.3, and the proportion of more than 4 lymph nodess metastases was 0% (0/45). When tumor invaded the adjacent structures of the esophagus (T-4), the lymph node metastasis rate was 85.7% (6/7); the mean number of metastatic lymph nodes was 5.1, and the proportion of more than 4 lymph nodes metastases was 71.4% (5/7). There was a significant difference between T-1 and T-4 (P < 0.01). The 5-year survival rate for patients without lymph node metastasis was 52.9%, for those with 1-4 nodes involved was 11.5%, and for patients with more than 4 positive nodes was 0.0% (P < 0.01). Conclusions There is a close association between tumor invasion depth and lymph node metastasis for adenocarcinoma of the esophagus and esophagogastric junction. Both the number and rate of lymph node metastasis are significantly correlated to the depth of tumor invasion. Moreover, when the tumor invades deeper into the esophageal wall, the percentage of patients with more than 4 involved nodes increases. Both the lymph node status and the number of metastatic nodes are important prognostic factors for the disease.
引用
收藏
页码:2268 / 2270
页数:3
相关论文
共 50 条
  • [1] Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction
    ZHANG Xun David I Watson Glyn G Jamieson Department of Thoracic Surgery
    中华医学杂志(英文版), 2007, (24) : 2268 - 2270
  • [2] The optimal lymph node dissection in patients with adenocarcinoma of the esophagogastric junction
    Okholm, Cecilie
    Fjederholt, Kaare Terp
    Mortensen, Frank Viborg
    Svendsen, Lars Bo
    Achiam, Michael Patrick
    SURGICAL ONCOLOGY-OXFORD, 2018, 27 (01): : 36 - 43
  • [3] Lymph node micrometastases in patients with adenocarcinoma of the esophagogastric junction
    Luigi Bonavina
    Stefano Ferrero
    Valeria Midolo
    Roberto Buffa
    Bruno Cesana
    Alberto Peracchia
    Journal of Gastrointestinal Surgery, 1999, 3 : 468 - 476
  • [4] Lymph node micrometastases in patients with adenocarcinoma of the esophagogastric junction
    Bonavina, L
    Ferrero, S
    Midolo, V
    Buffa, R
    Cesana, B
    Peracchia, A
    JOURNAL OF GASTROINTESTINAL SURGERY, 1999, 3 (05) : 468 - 476
  • [5] Lymph node metastasis and lymphadenectomy of resectable adenocarcinoma of the esophagogastric junction
    Chen, Xin-Zu
    Zhang, Wei-Han
    Hu, Jian-Kun
    CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (03) : 237 - 242
  • [6] Lymph node metastasis and lymphadenectomy of resectable adenocarcinoma of the esophagogastric junction
    Xin-Zu Chen
    Wei-Han Zhang
    Jian-Kun Hu
    Chinese Journal of Cancer Research, 2014, 26 (03) : 237 - 242
  • [7] Prognostic and Clinicopathological Significance of Lymph Node Metastasis in the Esophagogastric Junction Adenocarcinoma
    Urakawa, Naoki
    Kanaji, Shingo
    Suzuki, Satoshi
    Sawada, Ryuichiro
    Harada, Hitoshi
    Goto, Hironobu
    Hasegawa, Hiroshi
    Yamashita, Kimihiro
    Matsuda, Takeru
    Oshikiri, Taro
    Kakeji, Yoshihiro
    ANTICANCER RESEARCH, 2022, 42 (02) : 1051 - 1057
  • [8] Different lymph node staging systems for patients with adenocarcinoma of esophagogastric junction
    Zhou, Zhangjian
    Xie, Xin
    Hao, Nan
    Diao, Dongmei
    Song, Yongchun
    Xia, Peng
    Dang, Chengxue
    Zhang, Hao
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (06) : 963 - 970
  • [9] Priority of lymph node dissection for advanced esophagogastric junction adenocarcinoma with the tumor center located below the esophagogastric junction
    Cai, Ming-Zhi
    Lv, Chen-Bin
    Cai, Li-Sheng
    Chen, Qiu-Xian
    MEDICINE, 2019, 98 (51)
  • [10] Should the splenic hilar lymph node be dissected for the management of adenocarcinoma of the esophagogastric junction?
    Kumazu, Yuta
    Hasegawa, Shinichi
    Hayashi, Tsutomu
    Yamada, Takanobu
    Watanabe, Hayato
    Hara, Kentaro
    Shimoda, Yota
    Nakazono, Masato
    Nagasawa, Shinsuke
    Rino, Yasushi
    Masuda, Munetaka
    Ogata, Takashi
    Oshima, Takashi
    Yoshikawa, Takaki
    EJSO, 2023, 49 (01): : 76 - 82